SLT as primary therapy for POAG

Article

Effective at lowering pressure and repeatability make SLT first choice

Selective laser trabeculoplasty (SLT) has been applied in clinical practice since 2001. Before that time, the only laser surgery available to us that we could use in the chamber angle was argon laser trabeculoplasty (ALT). Compared with ALT, SLT is much better for the trabecular meshwork tissue and it has now completely eradicated the use of ALT. A number of studies in the literature comparing the two methods have demonstrated this.1

Fast, safe and effective method

Related Videos
Ana Neves, head of global marketing for ZEISS Meditec Ophthalmology
Fritz Hengerer, MD, PhD, Director, Eye Hospital at Bürgerhospital, Frankfurt, Germany
Dr Sheng Lim, professor of glaucoma studies at St Thomas' Hospital, London
Kasperi Kankare at the iCare booth at ESCRS
Scott D Barnes, MD, CMO of STAAR Surgical
Tomislav Bucalic, head of marketing at Geuder, and David Geuder, member of the executive board and CIO
Related Content
© 2023 MJH Life Sciences

All rights reserved.